Clik here to view.
Boston Tech Watch: GE, HubSpot, Fuze, MIT, Vesper, Quickhelp & More
It was a busy week in Boston tech. Here’s a recap of some of the latest headlines: —GE Healthcare and Partners HealthCare announced a 10-year partnership to develop artificial intelligence tools to...
View ArticleClik here to view.
Salesforce, Cloudflare Entice A.I. App Developers To Build On Their Platforms
Two big San Francisco tech companies put out the welcome mat for third party developers this week, hoping to enrich their platforms with new apps that make use of artificial intelligence tools and...
View ArticleClik here to view.
Devoted Health, Led by Athenahealth Alums Ed & Todd Park, Bags $62M
[Updated 10/23/17, 12:27 pm. See below.] Devoted Health, a new healthcare company created by former Athenahealth leaders, has raised nearly $62 million from investors, according to a document filed...
View ArticleClik here to view.
Cyteir Bags $29M to Tap “Self Destruct” in Cancers, Immune Diseases
The rapid growth of cancer cells actually damages them, leading them to rely on internal repair mechanisms. Scientists are finding ways to disrupt these repair features to fight the disease, and their...
View ArticleClik here to view.
Anti-Aging Startup Unity Bio Grabs $55M, Plans First Clinical Trial
[Updated, 3/19/18, 6:32 p.m. See below.] Unity Biotechnology is trying to treat age-related diseases where it says many of them start: the production of the cellular proteins that lead to the...
View ArticleClik here to view.
Virta Health Hauls in $45M to Expand “Diabetes-Reversing” Software
Virta Health, a startup that is taking a software approach to treating diabetes rather than pills or injections, has raised $45 million in funding to support its technology. San Francisco-based Virta...
View ArticleClik here to view.
As Telemedicine Use Booms, Doctor On Demand Raises $74M to Scale Up
Doctor On Demand, a startup that provides telemedicine services to patients who are unable or unwilling to see a doctor in person, says it has raised a $74 million round of outside financing. The new...
View ArticleClik here to view.
Salsify Grabs $43M to Help Brands Navigate Amazon & E-Commerce
In the online shopping age, it can be difficult for businesses to keep all of their product information updated and relevant to potential customers.Boston-based startup Salsify has spent several years...
View ArticleClik here to view.
Fresh Off GSK Deal, Gene Therapy Startup Orchard Bags Another $150M
Another gene therapy startup looks primed for an IPO. Orchard Therapeutics has just landed another $150 million to help drive forward a group of gene therapies it bought from British pharma company...
View ArticleClik here to view.
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
If you had more than $300 million to try and fix the healthcare industry, how would you do it?For a startup called Devoted Health, the answer involves a combination of providing more home healthcare...
View ArticleClik here to view.
6sense Raises $27M to Uncover Hidden Interests of B2B Buyers
Let’s say you’re wondering whether another software provider could do a better job for your business than the one you already use. You start a web search on its competitors. Suddenly, you get a...
View ArticleClik here to view.
Element Biosciences Lands $15M to Develop New Genetic Analysis Tools
Most of the genetic analysis done today is performed on machines made by Illumina, the DNA sequencing giant.Now a former director from the company is leading a startup that has raised $15 million to...
View ArticleClik here to view.
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
Despite the progress of gene therapy—a cutting edge medicine promising long-lasting effects from a single treatment—it remains a crude and limited tool. Startup Encoded Therapeutics has raised $104...
View ArticleClik here to view.
Sequencing Firm Adaptive’s $300M IPO Comes With Pharma Ambitions
If biotech’s historic bull run is losing steam, as some observers believe, this week is one hell of a final stampede.Adaptive Biotechnologies of Seattle just raised $300 million. BridgeBio Pharma of...
View ArticleClik here to view.
Cloudflare’s $525M IPO Emboldens Already-Confident Internet Booster
[Updated 9/13/19, 11:40 am ET. See below.] Cloudflare has had its share of controversy, and is in a market with a wide range of more established competitors, from Amazon Web Services and Google Cloud...
View ArticleClik here to view.
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug
Cyteir Therapeutics has $40.2 million more in cash to support early-stage tests of a drug intended to treat cancer by targeting a tumor repair mechanism.The new cash that Cyteir announced Tuesday adds...
View ArticleClik here to view.
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors
Cell therapies have helped treat some blood cancers, but toxic side effects are one limitation preventing their use in solid tumors.Amunix has, since its 2006 launch, licensed to biopharmas technology...
View ArticleClik here to view.
Keros Outlines IPO Plans Amid Markets Rocked by Coronavirus Pandemic
Keros Therapeutics, a biotech which raised more than $50 million this month in venture capital, is now looking to tap the public markets for additional cash amid a time of historic tumult.The...
View ArticleClik here to view.
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia
Diabetes drug giant Novo Nordisk has reached a $725 million deal to acquire Corvidia Therapeutics, a clinical-stage biotech developing treatments for disorders affecting the heart and the kidneys.The...
View ArticleClik here to view.
Federation Bio Bags $50M to Engineer New Approach to Microbiome Drugs
Scientists at microbiome therapy developers often talk about the importance of community, how the bugs in our gut act in concert in addition to their individual roles. That’s important for microbiome...
View Article
